Literature DB >> 16278098

Nonconvulsive status epilepticus due to cefepime in a patient with normal renal function.

Rama Maganti1, David Jolin, Daljeet Rishi, Amit Biswas.   

Abstract

Status epilepticus and encephalopathy have been reported with use of cephalosporins in patients with renal failure. We here report the case of a 79-year-old patient with normal renal function who developed subtle mental status changes during cefepime therapy for urinary tract infection. Emergent electroencephalography revealed evidence of nonconvulsive status epilepticus (NCSE), which responded initially to lorazepam. Later, the patient's NCSE gradually resolved only after cefepime was discontinued, with mental status returning to baseline as the electroencephalography changes resolved. It should be recognized that cefepime therapy can cause NCSE even in the presence of normal renal function. Measurement of serum concentrations and changes in dosing guidelines can probably prevent NCSE during cefepime therapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16278098     DOI: 10.1016/j.yebeh.2005.09.010

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  22 in total

1.  Cefixime-induced nonconvulsive status epilepticus.

Authors:  F Anzellotti; L Ricciardi; D Monaco; F Ciccocioppo; I Borrelli; H Zhuzhuni; M Onofrj
Journal:  Neurol Sci       Date:  2011-07-01       Impact factor: 3.307

2.  Cefepime neurotoxicity can mimic postanoxic coma with myoclonic status epilepticus.

Authors:  Sara Hocker; Alejandro A Rabinstein
Journal:  Neurol Clin Pract       Date:  2011-12

3.  Association of antibiotics with status epilepticus.

Authors:  Usha K Misra; Jayantee Kalita; Satish Chandra; Pradeep P Nair
Journal:  Neurol Sci       Date:  2012-03-07       Impact factor: 3.307

4.  Adequacy of high-dose cefepime regimen in febrile neutropenic patients with hematological malignancies.

Authors:  Fekade Bruck Sime; Michael S Roberts; Ing Soo Tiong; Julia H Gardner; Sheila Lehman; Sandra L Peake; Uwe Hahn; Morgyn S Warner; Jason A Roberts
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Cefepime-Associated SIRPIDs in a Patient With Normal Renal Function.

Authors:  Emily Johnson; Yousef Hannawi; Nirma Carballido Martinez; Eva K Ritzl
Journal:  Neurohospitalist       Date:  2015-10-14

6.  Prospective monitoring of cefepime in intensive care unit adult patients.

Authors:  Thomas M Chapuis; Eric Giannoni; Paul A Majcherczyk; René Chioléro; Marie-Denise Schaller; Mette M Berger; Saskia Bolay; Laurent A Décosterd; Denis Bugnon; Philippe Moreillon
Journal:  Crit Care       Date:  2010-04-01       Impact factor: 9.097

Review 7.  Management of meningitis due to antibiotic-resistant Acinetobacter species.

Authors:  Baek-Nam Kim; Anton Y Peleg; Thomas P Lodise; Jeffrey Lipman; Jian Li; Roger Nation; David L Paterson
Journal:  Lancet Infect Dis       Date:  2009-04       Impact factor: 25.071

Review 8.  Cefepime-induced nonconvulsive status epilepticus: case report and review.

Authors:  Farah Thabet; Mohamed Al Maghrabi; Ahmed Al Barraq; Brahim Tabarki
Journal:  Neurocrit Care       Date:  2008-11-25       Impact factor: 3.210

9.  Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem.

Authors:  Akihiro Tanaka; Kenshi Takechi; Shinichi Watanabe; Mamoru Tanaka; Katsuya Suemaru; Hiroaki Araki
Journal:  Int J Clin Pharm       Date:  2013-06-04

10.  Clinical, Electroencephalographic Features and Prognostic Factors of Cefepime-Induced Neurotoxicity: A Retrospective Study.

Authors:  Han-Tao Li; Chih-Hong Lee; Tony Wu; Mei-Yun Cheng; Wei-En Johnny Tseng; Chun-Wei Chang; Hsiang-Yao Hsieh; Hsing-I Chiang; Chih-Yin Lin; Bao-Luen Chang; Wey-Ran Lin; Siew-Na Lim
Journal:  Neurocrit Care       Date:  2019-10       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.